Singapore Pushes Back as US Levies Hit on Forced-Labor Claim
Original Report
Singapore’s top diplomat said there was no economic justification for the US to impose tariffs on the city-state, adding that it seeks to avoid becoming “collateral damage” in Washington’s broader...
Singapore’s top diplomat said there was no economic justification for the US to impose tariffs on the city-state, adding that it seeks to avoid becoming “collateral damage” in Washington’s broader trade policy.
Glass House Analysis
International economic policy has concrete impacts far beyond diplomatic circles. Tariffs show up in the price of goods at stores, supply chain disruptions affect whether products are on shelves, and trade tensions can mean job losses in export-dependent industries. The globalized economy means that decisions made abroad can affect workers and consumers domestically.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
Japan core inflation rate in June creeps up from 4-year low as higher oil prices bite
This is the first rise in core inflation since March, and was in line with the1.6% growth expected by economists polled by Reuters.
U.S. to see higher generic drug prices thanks to tariffs, CEO of leading India pharma firm warns
CEO of Indian pharma company Dr Reddy's has warned that Trump's proposed tariffs on generic drugs will make them more expensive for patients.
Manipal Health Seeks to Raise Up to $960 Million in India IPO
Manipal Health Enterprises Ltd. is seeking to raise as much as 92.7 billion rupees ($960 million) in an initial public offering, continuing a run of sizable share sales in India.
China's largest memory chipmaker sparks fears of a cash drain as it readies for public debut
CXMT is stoking fears that its blockbuster stock market debut could pull cash from China's equities.